China’s“three-child policy”,implemented in response to population aging,has made the protection of maternal and infant health an urgent priority.In this environmental and medical big-data era,the Zhejiang Environme...China’s“three-child policy”,implemented in response to population aging,has made the protection of maternal and infant health an urgent priority.In this environmental and medical big-data era,the Zhejiang Environmental and Birth Health Research Alliance(ZEBRA)maternity cohort was established with the aim of identifying risk factors for perinatal morbidity and mortality from the perspectives of both observational epidemiology and experimental etiology.Compared with conventional birth cohorts,the inclusion of a maternity cohort allows greater scope for research and places an emphasis on maternal health.In particular,it allows us to focus on pregnant women with a history of pregnancy-related illnesses and those planning to have a second or third child.There are currently many pressing issues in perinatal health,including the risk associations between exogenous together with endogenous factors and the occurrence of perinatal abnormalities,pregnancy complications,and adverse pregnancy outcomes.It is crucial to explore the interaction between environmental exposures and genetic factors affecting perinatal health if we are to improve it.It is also worthwhile to assess the feasibility of the early stage prediction of major perinatal abnormalities.We hope to study this in the ZEBRA cohort and also seek nationwide and international collaborations to establish a multicenter cohort consortium,with the ultimate goal of contributing epidemiological evidence to literature and providing evidence-based insights for global maternal and child healthcare.展开更多
ACHIEVEMENTS AND CHALLENGES Before the advent ofmodern medicine,childbirth carried extremely high risk of mortality,both maternal and perinatal(the period beginning at the 20–28th week of gestation and ending at 1–4...ACHIEVEMENTS AND CHALLENGES Before the advent ofmodern medicine,childbirth carried extremely high risk of mortality,both maternal and perinatal(the period beginning at the 20–28th week of gestation and ending at 1–4 weeks after delivery).Fortunately,with advances in prenatal healthcare,the prevalence of maternal and perinatal mortalities has significantly reduced.A press conference held on May 30,2022,by the National Health Commission of the People’s Republic of China,reviewed the major progress and achievements in Chinese maternal and child health over the past decade.It highlighted that the maternal mortality rate dropped to 161 per million in 2021,the lowest level in recorded history.展开更多
基金funding from various sources,including the Zhejiang Province Health Innovative Talent Project(A0466)the International Cooperation Seed Program of Women’s Hospital,Zhejiang University(GH2022B008-01 and GH2024005)+3 种基金the Australian Research Council(DP210102076)the Australian National Health and Medical Research Council(APP2000581)the UK Research and Innovation(UKRI)Centre for Application of Artificial Intelligence to the Study of Environmental Risks(AI4ER,EP/S022961/1)the Start-up Grant from Yong Loo Lin School of Medicine,National University of Singapore(NUHSRO/2024/045/Startup/06),and the US-China Fulbright Program.
文摘China’s“three-child policy”,implemented in response to population aging,has made the protection of maternal and infant health an urgent priority.In this environmental and medical big-data era,the Zhejiang Environmental and Birth Health Research Alliance(ZEBRA)maternity cohort was established with the aim of identifying risk factors for perinatal morbidity and mortality from the perspectives of both observational epidemiology and experimental etiology.Compared with conventional birth cohorts,the inclusion of a maternity cohort allows greater scope for research and places an emphasis on maternal health.In particular,it allows us to focus on pregnant women with a history of pregnancy-related illnesses and those planning to have a second or third child.There are currently many pressing issues in perinatal health,including the risk associations between exogenous together with endogenous factors and the occurrence of perinatal abnormalities,pregnancy complications,and adverse pregnancy outcomes.It is crucial to explore the interaction between environmental exposures and genetic factors affecting perinatal health if we are to improve it.It is also worthwhile to assess the feasibility of the early stage prediction of major perinatal abnormalities.We hope to study this in the ZEBRA cohort and also seek nationwide and international collaborations to establish a multicenter cohort consortium,with the ultimate goal of contributing epidemiological evidence to literature and providing evidence-based insights for global maternal and child healthcare.
基金supports in the establishment of ZEBRA.Research receives funding from Zhejiang Province Health Innovative Talent Project(A0466)and International Cooperation Seed ProgramofWomen’s Hospital,Zhejiang University(GH2022B008-01).
文摘ACHIEVEMENTS AND CHALLENGES Before the advent ofmodern medicine,childbirth carried extremely high risk of mortality,both maternal and perinatal(the period beginning at the 20–28th week of gestation and ending at 1–4 weeks after delivery).Fortunately,with advances in prenatal healthcare,the prevalence of maternal and perinatal mortalities has significantly reduced.A press conference held on May 30,2022,by the National Health Commission of the People’s Republic of China,reviewed the major progress and achievements in Chinese maternal and child health over the past decade.It highlighted that the maternal mortality rate dropped to 161 per million in 2021,the lowest level in recorded history.
